课题基金 / 基金详情

COVID 19 - The Hidden Rise in Toxic Air Pollution during the COVID-19 Pandemic: is our response worsening the respiratory burden of particulate matter

COVID 19 - The Hidden Rise in Toxic Air Pollution during the COVID-19 Pandemic: is our response worsening the respiratory burden of particulate matter
COVID 19 - COVID-19 大流行期间有毒空气污染的隐性增长:我们的应对措施是否加剧了颗粒物的呼吸负担
批准号:
NE/V009400/1
负责人:
Kevin Wyche
金额:
$6.73万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --
关键词:

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent research has highlighted the concerning paradigm that reducing ambient concentrations of legislated air pollution, in the form of PM2.5, may lead to a decline in air quality by increasing the concentration of more harmful ultrafine particles (UFP; diameter less than 100nm). It has been shown that PM2.5 plays a crucial role in suppression of UFP numbers, with larger PM2.5 particles acting to scavenge the more toxic UFP from the air. Consequently, removal of PM2.5 as a UFP sink may result in enhanced ambient UFP numbers, particularly if UFP emissions and gaseous precursor concentrations remain unchecked. With the outbreak of the COVID-19 pandemic, anthropogenic activity around the globe has decreased in a vast and unprecedented manner, to such an extent that concentrations of commonly measured primary air pollutants have decreased dramatically. However, levels of secondary pollutants (which often correlate with finest UFP fractions) have already begun to rise. It follows that this sudden, global drop in anthropogenic activity and ambient PM2.5 has the potential to drive an unexpected and potentially significant increase in UFP concentrations and associated detrimental health effects. If we are now inadvertently adding an unlooked-for cardio-respiratory pollutant into the air at a time when many are vulnerable to a virus that impacts the respiratory system, we risk widening the COVID-19 'window of vulnerability', where increased UFP exposure acts to exacerbate underlying conditions for individuals with pre-existing co-morbidities, who may otherwise be considered 'lower risk', and worsen the impact of the virus for those already considered as 'at risk'.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.scitotenv.2020.142526
发表时间: 2021-02-10
期刊: The Science of the total environment
影响因子: --
作者: [Wyche KP, Nichols M, Parfitt H, Beckett P, Gregg DJ, Smallbone KL, Monks PS]
通讯作者: Monks PS
国内基金
海外基金
芽孢杆菌TR19-1对魔芋腐皮镰刀菌拮抗机理研究
1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
ATPIF1调节线粒体膜电位影响靶向CD19 CAR-T细胞抗肿瘤活性的作用及机制
  • 批准号:
    2026JJ80001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    钟根深
  • 依托单位:
CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
  • 批准号:
    2026JJ81339
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢希
  • 依托单位: